Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EPS (Basic) (2020 - 2025)

Stemtech (STEK) has disclosed EPS (Basic) for 6 consecutive years, with -$0.01 as the latest value for Q3 2025.

  • Quarterly EPS (Basic) changed 0.0% to -$0.01 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$0.02 through Sep 2025, up 66.67% year-over-year, with the annual reading at -$0.03 for FY2024, 57.14% up from the prior year.
  • EPS (Basic) hit -$0.01 in Q3 2025 for Stemtech, down from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.38 in Q3 2022 to a low of -$0.56 in Q2 2022.
  • Historically, EPS (Basic) has averaged -$0.02 across 5 years, with a median of -$0.01 in 2022.
  • Biggest five-year swings in EPS (Basic): skyrocketed 370.0% in 2021 and later crashed 2700.0% in 2022.
  • Year by year, EPS (Basic) stood at $0.27 in 2021, then tumbled by 103.7% to -$0.01 in 2022, then tumbled by 100.0% to -$0.02 in 2023, then soared by 83.29% to -$0.0 in 2024, then tumbled by 199.3% to -$0.01 in 2025.
  • Business Quant data shows EPS (Basic) for STEK at -$0.01 in Q3 2025, -$0.0 in Q2 2025, and -$0.01 in Q1 2025.